 |
Immucor Acquires BioArray Solutions
 |
Immucor, Inc. is a leading supplier of diagnostic reagents and automated instrumentation to ensure the safety of blood transfusions |
|
Immucor is publicly traded on NASDAQ under the symbol BLUD with a market value of over $1.5 billion |
|
BioArray Solutions Ltd. has pioneered the development of advanced genotyping technology for blood transfusions |
|
TM Capital assisted Immucor in negotiating its acquisition of BioArray |
 Client Press Release
|
MedTech Completes Recapitalization
Dinex Acquired by Carlisle Companies
Immucor Acquires BioArray Solutions
Immucor Forms Joint Venture with Kainos
Immucor Acquires Gamma Biologicals
SteriGenics Acquired by IBA
SteriGenics Acquires Nicolet from Thermo
Portland Professional Acquired by NMHC
Jensen Completes Recapitalization
Heico Sells Meditek to U.S. Diagnostic Labs
Medical Diagnostics Acquired by ANMR
Medcom Acquired by Quintiles
Armstrong Pharma Acquired by Medeva
International Murex Completes Financing
Immucor Acquires Division of Biopool
Immucor Completes Debt Restructuring
Immucor Board of Directors Re-Elected
Immucor Goodwill Valuation Analysis
SteriGenics Acquires Irradiation Industries
SteriGenics Int'l Acquires RTI
BioLok Acquired by Healthpoint Capital
